DH4P is about sharing, learning and gaining practical insights that enable pharma commercial teams leverage digital health to have an eventual commercial impact. The opening keynote applies what we learned since the infancy of digital health to form the basis of a new “digital health for pharma” market vision. We will share this vision for the future, including external healthcare, technology and commercial pharma dynamics, implications and digital opportunities along a continuum that can be leveraged by every life science organization from digitally naïve to digitally mature.
There is unbridled excitement and investment in digital health technologies, but relatively little evidence about whether they are improving patient outcomes or enhancing value of care. In this talk, Dr. Brennan Spiegel, Director of Health Services Research at Cedars-Sinai in Los Angeles, will discuss the evidence about what works—and what doesn’t work—using health technology in the clinical trenches. With examples ranging from use of virtual reality, to wearable biosensors, to smartphone applications, Dr. Spiegel will discuss the nitty-gritty details about their successes and failures using digital health in everyday care.
Recognizing how and when our industry should partner with the Digital Health Ecosystem to drive value for our customers and our brands. Understanding the complex dynamics of the changing healthcare landscape and the tremendous opportunities for Life Science organizations to adapt and evolve via external collaborations. Learn the Do’s and Don’ts and develop partnerships that dramatically enhance the value proposition of life science brands to drive commercial impact for those brands by achieving customer goals
How do we create a better experience for patients, clinical researchers, regulators and colleagues by modernizing clinical trials. Some real-life examples of where Pfizer has utilized technology to automate some highly manual processes, to create new experiences with patients through the use of digital technologies in clinical trials, integrate with EMR systems to reduce redundancy of data collection and to bring clinical trials to patients. A look at the successes and challenges, including change management, as we transform highly complex and regulated processes into more efficient and rewarding experiences.
Perspectives from an industry pioneer in digital on what it takes for life sciences organizations to drive successful (not easy) impact with Digital Health. Real life examples taken from the perspective of the Board and C-Suite on what pharma and digital health providers can and must do together to accelerate adoption and impact.
Digital technology can transform both therapies and research beyond what we see today. The rapid evolution of wearable devices and mobile health technology is creating a marketplace that provides many options for digital healthcare. But which device is the best? They all are – depending on what you’re trying to do. The lack of know-how to understand and validate sensors, devices, data, and algorithms are preventing us from fulfilling the full promise of digital health. Learn how to begin making sense of sensors
The average patient commutes one hour and sixteen minutes to get to their doctor’s appointment and waits another 19 minutes in the lobby for their doctor. The average wait time for a telemedicine patient to set up and wait? Six to nine minutes.
Telemedicine is redefining the customer experience and customer expectations. It’s up to us as pharma marketers to push boundaries – compliantly – and serve to the patient’s needs.
The Growth of Telemedicine:
The search for the right Telemed partner
Preparing your internal team for telemedicine;
Getting internal stakeholder buy-in
How does a pharma company partner with Telemed and stay compliant?
Dos and Don’ts
Examples of what works/what doesn’t
Patient Experience:
Why telemedicine is the right channel for women’s health;
Patient expectations
Starting out;
Training materials for HCPs
Where did we end up;
User case studies: Testing, issues, etc.
Key learnings
Campaign Execution
Consumer Messaging
How we position telemedicine on our owned properties
Creative Execution and where we promote and reach patients
Pre-Launch: Creating a “line-up” experience to drive early demand
Limited access and lack of specialty practitioners inevitably leave gaps in care delivery and treatment as they fail to provide an all-encompassing solution that is flexible and responsive to the time-sensitive, complex needs of people with chronic conditions. Integrated and condition specific virtual care that combines the human touch of clinical expertise with data-integrated technologies will pave the way for a new gold standard in chronic condition management. This scalable and innovative approach to managing chronic conditions will improve care, adherence, drive better patient outcomes and reduce the ballooning cost of healthcare.
Come learn how is Bayer leveraging data and technology to develop better solutions for a growing and aging populating via different examples in health and agriculture.
Digital Health Interventions offer tremendous promise in increasing the value of life science brands is improving patient health outcomes, reducing overall costs of care and improving care quality. Learn from pioneers and thought-leaders in digital health about the best ways to approach creating and demonstrating this value to payers
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
